{"id":828685,"date":"2025-03-22T12:13:08","date_gmt":"2025-03-22T16:13:08","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-integra-lifesciences-holdings-corporation-nasdaq-iart-shareholders-grabar-law-investigates-claims-on-your-behalf-2\/"},"modified":"2025-03-22T12:13:08","modified_gmt":"2025-03-22T16:13:08","slug":"notice-to-long-term-integra-lifesciences-holdings-corporation-nasdaq-iart-shareholders-grabar-law-investigates-claims-on-your-behalf-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-integra-lifesciences-holdings-corporation-nasdaq-iart-shareholders-grabar-law-investigates-claims-on-your-behalf-2\/","title":{"rendered":"Notice to Long-Term Integra Lifesciences Holdings Corporation (NASDAQ: IART) Shareholders: Grabar Law Investigates Claims on Your Behalf"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">PHILADELPHIA, March  22, 2025  (GLOBE NEWSWIRE) &#8212; Grabar Law Office is investigating whether the Board of Directors of Integra LifeSciences Holdings Corp. (NASDAQ: IART) breached their fiduciary duties owed to the Company.<\/p>\n<p align=\"justify\">\n        <strong>Current Integra LifeSciences Holdings Corp. (NASDAQ: IART) shareholders who have held the stock since on or before <\/strong><br \/>\n        <strong>March 11, 2019<\/strong><br \/>\n        <strong>, <\/strong><br \/>\n        <strong>can <\/strong><br \/>\n        <strong>seek corporate reforms, the return of funds spent defending litigation back to the company, and a court approved incentive award, at no cost to them.<\/strong>\u00a0\u00a0 <strong>Learn more or join at: <\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=LyguNRg7v0Dn3aI_7Ejj6xNPfdVhJgWHvPWvoVhv8yMu0qJs9OV-b2BMcAgOSz9MnpWDYYwgpNyVsan7gBtwpM9iInFB2jghGihE724K1-5lnO0kl3jJIz4WXMg9rTgLhefCYIUcjVoeuoYcM6yIKAgF537F5NcJ3NZXb6DtxC10M76wcXca59rxG1AbPbCOuxtVwEI4lLq_G0gtXKbsXzu53sPpalUaY9o8SNW_Jazhczl0VYfJMQlEF48C9RFt\" rel=\"nofollow\" target=\"_blank\"><strong>https:\/\/grabarlaw.com\/the-latest\/intrga-lifesciences-shareholder-investigation\/<\/strong><\/a><strong>. Contact Joshua H. Grabar at <\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tkNXkM1nmIoV7Hl16ec6gM8aDPwXxhAPuEVz6hfJbN2x8v4aICHsHb3S9Dw6BZYvYRLyh-FkBxGACWb3XX_V1M4vXiuQg4jbgIHMX_P5E5A=\" rel=\"nofollow\" target=\"_blank\"><strong>jgrabar@grabarlaw.com<\/strong><\/a><strong><u>,<\/u><\/strong><strong> or call 267-507-6085<\/strong>.<\/p>\n<p align=\"justify\">\n        <strong>WHY<\/strong><br \/>\n        <strong>:<\/strong> An underlying securities fraud class action complaint alleges that Integra, via certain of his officers and directors, repeatedly touted that it was on track to grow SurgiMend\u2019s market by obtaining FDA approval for use in post-mastectomy reconstruction, yet on May 23, 2023, the Company was forced to announce a \u201crecall\u201d of all products manufactured at its Boston Facility between March 1, 2018 and May 22, 2023. Integra LifeSciences explained that it had determined that the Boston Facility deviated from good manufacturing practices in testing for bacterial endotoxin and allowed the release of products with unsafe levels of endotoxins. As a result of the recall and manufacturing shutdown, the Company revised its guidance for the second quarter of 2023, lowering its revenue expectations by and disclosed that it expected to take a $22 million impairment due to the inventory write-off.<\/p>\n<p align=\"justify\">\n        <strong>WHAT TO DO NOW:<\/strong> Current Integra LifeSciences shareholders who have held Integra LifeSciences shares since on or before March 11, 2019, can seek corporate reforms, the return of funds spent defending litigation back to the company, and a court approved incentive award, at no cost to them.<\/p>\n<p align=\"justify\">\n        <strong>If you<\/strong><br \/>\n        <strong> would like to learn more about this matter, you are encouraged to visit <\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=LyguNRg7v0Dn3aI_7Ejj6xNPfdVhJgWHvPWvoVhv8yMu0qJs9OV-b2BMcAgOSz9MnpWDYYwgpNyVsan7gBtwpM9iInFB2jghGihE724K1-7sG6z_832Th4XSuDL74RIc1aygOhAFEv9ohEpBnzXDT0XtNZ0JY_9_o76s_SaXXWcl16NXcPTq1m6vCC3i4H0nph0e_THAF5p-xTMK5kf4tYqHEEpd4IxKhC4PlD9clWwGA8uOz2T60fQHwsGaUjF_\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <strong>https:\/\/grabarlaw.com\/the-latest\/intrga-lifesciences-shareholder-investigation\/<\/strong><br \/>\n        <\/a><br \/>\n        <strong>, <\/strong>contact Joshua H. Grabar at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tkNXkM1nmIoV7Hl16ec6gM8aDPwXxhAPuEVz6hfJbN18LgeEWIvufneIJXWarVXNPMDy5_7Ft5Nv6VLa7vy0QuTPY21ZCZgxLO7i9npBLd0=\" rel=\"nofollow\" target=\"_blank\">jgrabar@grabarlaw.com<\/a>, or call us at 267-507-6085. $IART #IntegraLifeSciences<\/p>\n<p align=\"justify\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Guns-FwAVN7btZQ2OCZX_e52bfOUtHjrpvMzi4_dCxXgOf-YG5F8L4O1bPRDf88v_fw7fhn2pwKRCpN1xVlm4ockQrtTagr-QN_JaYo78Vnc_OrqQdoqzbQzMtkZ3mytA1zReMIuqREstOExBh8VhA==\" rel=\"nofollow\" target=\"_blank\">Attorney Advertising Disclaimer<\/a>\n      <\/p>\n<p align=\"justify\">Contact:<br \/>Joshua H. Grabar, Esq.<br \/>Grabar Law Office<br \/>One Liberty Place<br \/>1650 Market Street, Suite 3600<br \/>Philadelphia, PA 19103<br \/>Tel: \u00a0267-507-6085<br \/>Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tkNXkM1nmIoV7Hl16ec6gM8aDPwXxhAPuEVz6hfJbN2FNNOq1LtT44Ditc905w1oS978WYlZNE61xwiQBths5Q4WcryVUL4ntvI0-IqG1m4=\" rel=\"nofollow\" target=\"_blank\">jgrabar@grabarlaw.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5OTE1NCM2ODE5Mzg5IzIyMDEyNzA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NDA0ZWVlYjQtOTRiNS00ZjUwLWFhMWYtNTUxMWMzMDg5MDQ3LTEyMTI4MjMtMjAyNS0wMy0yMi1lbg==\/tiny\/Grabar-Law-Office.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>PHILADELPHIA, March 22, 2025 (GLOBE NEWSWIRE) &#8212; Grabar Law Office is investigating whether the Board of Directors of Integra LifeSciences Holdings Corp. (NASDAQ: IART) breached their fiduciary duties owed to the Company. Current Integra LifeSciences Holdings Corp. (NASDAQ: IART) shareholders who have held the stock since on or before March 11, 2019 , can seek corporate reforms, the return of funds spent defending litigation back to the company, and a court approved incentive award, at no cost to them.\u00a0\u00a0 Learn more or join at: https:\/\/grabarlaw.com\/the-latest\/intrga-lifesciences-shareholder-investigation\/. Contact Joshua H. Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. WHY : An underlying securities fraud class action complaint alleges that Integra, via certain of his officers and directors, repeatedly touted that it was on track &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-integra-lifesciences-holdings-corporation-nasdaq-iart-shareholders-grabar-law-investigates-claims-on-your-behalf-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Notice to Long-Term Integra Lifesciences Holdings Corporation (NASDAQ: IART) Shareholders: Grabar Law Investigates Claims on Your Behalf&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-828685","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Notice to Long-Term Integra Lifesciences Holdings Corporation (NASDAQ: IART) Shareholders: Grabar Law Investigates Claims on Your Behalf - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-integra-lifesciences-holdings-corporation-nasdaq-iart-shareholders-grabar-law-investigates-claims-on-your-behalf-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Notice to Long-Term Integra Lifesciences Holdings Corporation (NASDAQ: IART) Shareholders: Grabar Law Investigates Claims on Your Behalf - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PHILADELPHIA, March 22, 2025 (GLOBE NEWSWIRE) &#8212; Grabar Law Office is investigating whether the Board of Directors of Integra LifeSciences Holdings Corp. (NASDAQ: IART) breached their fiduciary duties owed to the Company. Current Integra LifeSciences Holdings Corp. (NASDAQ: IART) shareholders who have held the stock since on or before March 11, 2019 , can seek corporate reforms, the return of funds spent defending litigation back to the company, and a court approved incentive award, at no cost to them.\u00a0\u00a0 Learn more or join at: https:\/\/grabarlaw.com\/the-latest\/intrga-lifesciences-shareholder-investigation\/. Contact Joshua H. Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. WHY : An underlying securities fraud class action complaint alleges that Integra, via certain of his officers and directors, repeatedly touted that it was on track &hellip; Continue reading &quot;Notice to Long-Term Integra Lifesciences Holdings Corporation (NASDAQ: IART) Shareholders: Grabar Law Investigates Claims on Your Behalf&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-integra-lifesciences-holdings-corporation-nasdaq-iart-shareholders-grabar-law-investigates-claims-on-your-behalf-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-22T16:13:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5OTE1NCM2ODE5Mzg5IzIyMDEyNzA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/notice-to-long-term-integra-lifesciences-holdings-corporation-nasdaq-iart-shareholders-grabar-law-investigates-claims-on-your-behalf-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/notice-to-long-term-integra-lifesciences-holdings-corporation-nasdaq-iart-shareholders-grabar-law-investigates-claims-on-your-behalf-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Notice to Long-Term Integra Lifesciences Holdings Corporation (NASDAQ: IART) Shareholders: Grabar Law Investigates Claims on Your Behalf\",\"datePublished\":\"2025-03-22T16:13:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/notice-to-long-term-integra-lifesciences-holdings-corporation-nasdaq-iart-shareholders-grabar-law-investigates-claims-on-your-behalf-2\\\/\"},\"wordCount\":352,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/notice-to-long-term-integra-lifesciences-holdings-corporation-nasdaq-iart-shareholders-grabar-law-investigates-claims-on-your-behalf-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5OTE1NCM2ODE5Mzg5IzIyMDEyNzA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/notice-to-long-term-integra-lifesciences-holdings-corporation-nasdaq-iart-shareholders-grabar-law-investigates-claims-on-your-behalf-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/notice-to-long-term-integra-lifesciences-holdings-corporation-nasdaq-iart-shareholders-grabar-law-investigates-claims-on-your-behalf-2\\\/\",\"name\":\"Notice to Long-Term Integra Lifesciences Holdings Corporation (NASDAQ: IART) Shareholders: Grabar Law Investigates Claims on Your Behalf - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/notice-to-long-term-integra-lifesciences-holdings-corporation-nasdaq-iart-shareholders-grabar-law-investigates-claims-on-your-behalf-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/notice-to-long-term-integra-lifesciences-holdings-corporation-nasdaq-iart-shareholders-grabar-law-investigates-claims-on-your-behalf-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5OTE1NCM2ODE5Mzg5IzIyMDEyNzA=\",\"datePublished\":\"2025-03-22T16:13:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/notice-to-long-term-integra-lifesciences-holdings-corporation-nasdaq-iart-shareholders-grabar-law-investigates-claims-on-your-behalf-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/notice-to-long-term-integra-lifesciences-holdings-corporation-nasdaq-iart-shareholders-grabar-law-investigates-claims-on-your-behalf-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/notice-to-long-term-integra-lifesciences-holdings-corporation-nasdaq-iart-shareholders-grabar-law-investigates-claims-on-your-behalf-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5OTE1NCM2ODE5Mzg5IzIyMDEyNzA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5OTE1NCM2ODE5Mzg5IzIyMDEyNzA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/notice-to-long-term-integra-lifesciences-holdings-corporation-nasdaq-iart-shareholders-grabar-law-investigates-claims-on-your-behalf-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Notice to Long-Term Integra Lifesciences Holdings Corporation (NASDAQ: IART) Shareholders: Grabar Law Investigates Claims on Your Behalf\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Notice to Long-Term Integra Lifesciences Holdings Corporation (NASDAQ: IART) Shareholders: Grabar Law Investigates Claims on Your Behalf - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-integra-lifesciences-holdings-corporation-nasdaq-iart-shareholders-grabar-law-investigates-claims-on-your-behalf-2\/","og_locale":"en_US","og_type":"article","og_title":"Notice to Long-Term Integra Lifesciences Holdings Corporation (NASDAQ: IART) Shareholders: Grabar Law Investigates Claims on Your Behalf - Market Newsdesk","og_description":"PHILADELPHIA, March 22, 2025 (GLOBE NEWSWIRE) &#8212; Grabar Law Office is investigating whether the Board of Directors of Integra LifeSciences Holdings Corp. (NASDAQ: IART) breached their fiduciary duties owed to the Company. Current Integra LifeSciences Holdings Corp. (NASDAQ: IART) shareholders who have held the stock since on or before March 11, 2019 , can seek corporate reforms, the return of funds spent defending litigation back to the company, and a court approved incentive award, at no cost to them.\u00a0\u00a0 Learn more or join at: https:\/\/grabarlaw.com\/the-latest\/intrga-lifesciences-shareholder-investigation\/. Contact Joshua H. Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. WHY : An underlying securities fraud class action complaint alleges that Integra, via certain of his officers and directors, repeatedly touted that it was on track &hellip; Continue reading \"Notice to Long-Term Integra Lifesciences Holdings Corporation (NASDAQ: IART) Shareholders: Grabar Law Investigates Claims on Your Behalf\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-integra-lifesciences-holdings-corporation-nasdaq-iart-shareholders-grabar-law-investigates-claims-on-your-behalf-2\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-22T16:13:08+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5OTE1NCM2ODE5Mzg5IzIyMDEyNzA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-integra-lifesciences-holdings-corporation-nasdaq-iart-shareholders-grabar-law-investigates-claims-on-your-behalf-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-integra-lifesciences-holdings-corporation-nasdaq-iart-shareholders-grabar-law-investigates-claims-on-your-behalf-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Notice to Long-Term Integra Lifesciences Holdings Corporation (NASDAQ: IART) Shareholders: Grabar Law Investigates Claims on Your Behalf","datePublished":"2025-03-22T16:13:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-integra-lifesciences-holdings-corporation-nasdaq-iart-shareholders-grabar-law-investigates-claims-on-your-behalf-2\/"},"wordCount":352,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-integra-lifesciences-holdings-corporation-nasdaq-iart-shareholders-grabar-law-investigates-claims-on-your-behalf-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5OTE1NCM2ODE5Mzg5IzIyMDEyNzA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-integra-lifesciences-holdings-corporation-nasdaq-iart-shareholders-grabar-law-investigates-claims-on-your-behalf-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-integra-lifesciences-holdings-corporation-nasdaq-iart-shareholders-grabar-law-investigates-claims-on-your-behalf-2\/","name":"Notice to Long-Term Integra Lifesciences Holdings Corporation (NASDAQ: IART) Shareholders: Grabar Law Investigates Claims on Your Behalf - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-integra-lifesciences-holdings-corporation-nasdaq-iart-shareholders-grabar-law-investigates-claims-on-your-behalf-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-integra-lifesciences-holdings-corporation-nasdaq-iart-shareholders-grabar-law-investigates-claims-on-your-behalf-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5OTE1NCM2ODE5Mzg5IzIyMDEyNzA=","datePublished":"2025-03-22T16:13:08+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-integra-lifesciences-holdings-corporation-nasdaq-iart-shareholders-grabar-law-investigates-claims-on-your-behalf-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-integra-lifesciences-holdings-corporation-nasdaq-iart-shareholders-grabar-law-investigates-claims-on-your-behalf-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-integra-lifesciences-holdings-corporation-nasdaq-iart-shareholders-grabar-law-investigates-claims-on-your-behalf-2\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5OTE1NCM2ODE5Mzg5IzIyMDEyNzA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5OTE1NCM2ODE5Mzg5IzIyMDEyNzA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/notice-to-long-term-integra-lifesciences-holdings-corporation-nasdaq-iart-shareholders-grabar-law-investigates-claims-on-your-behalf-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Notice to Long-Term Integra Lifesciences Holdings Corporation (NASDAQ: IART) Shareholders: Grabar Law Investigates Claims on Your Behalf"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/828685","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=828685"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/828685\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=828685"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=828685"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=828685"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}